CN106674486A - Polyester type polyurethane material with side chain containing phosphorylcholine group and preparation method thereof - Google Patents

Polyester type polyurethane material with side chain containing phosphorylcholine group and preparation method thereof Download PDF

Info

Publication number
CN106674486A
CN106674486A CN201611235863.2A CN201611235863A CN106674486A CN 106674486 A CN106674486 A CN 106674486A CN 201611235863 A CN201611235863 A CN 201611235863A CN 106674486 A CN106674486 A CN 106674486A
Authority
CN
China
Prior art keywords
preparation
phosphorylcholine
side chain
polyurethane material
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201611235863.2A
Other languages
Chinese (zh)
Other versions
CN106674486B (en
Inventor
侯昭升
张娜
刘小龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Jieshida New Material Co ltd
Original Assignee
Shandong Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Normal University filed Critical Shandong Normal University
Priority to CN201611235863.2A priority Critical patent/CN106674486B/en
Publication of CN106674486A publication Critical patent/CN106674486A/en
Application granted granted Critical
Publication of CN106674486B publication Critical patent/CN106674486B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/80Masked polyisocyanates
    • C08G18/8003Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen
    • C08G18/8006Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32
    • C08G18/8009Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203
    • C08G18/8012Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203 with diols
    • C08G18/8016Masked aliphatic or cycloaliphatic polyisocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/42Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269Lactones
    • C08G18/4277Caprolactone and/or substituted caprolactone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/42Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/428Lactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2230/00Compositions for preparing biodegradable polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

The invention relates to a polyester type polyurethane material with a side chain containing a phosphorylcholine group and a preparation method thereof. The preparation method comprises the following steps of: (1) causing polyester glycol react with excessive diisocyanate, thereby acquiring a double-end isocyanate group prepolymer; and (2) adopting a phosphorylcholine compound containing two amino groups for expanding the chain of the double-end isocyanate group prepolymer, thereby acquiring a biodegradable polyurethane material with the side chain containing the phosphorylcholine group. The phosphorylcholine group in the polyurethane material is located on the side chain of the polymer, so that the biocompatibility of the material can be effectively promoted under the condition of low content of the phosphorylcholine group. Soft segments of the material are all made from polyester; the degree of crystallinity is higher; the higher mechanical strength of the material is guaranteed; the main chain is fully hydrophobic; the degradation velocity is low; the polyurethane material, which is used as a tissue engineering repairing holder material, and the like, can be long-term applied to organism; after the material acts, the material can be gradually degraded into non-toxic products and then absorbed by the organism, so that the injury of the second operation can be avoided.

Description

A kind of side chain group containing Phosphorylcholine polyester type polyurethane material and preparation method thereof
Technical field
The invention belongs to can medical macromolecular materials field, and in particular to a kind of side chain group containing Phosphorylcholine polyester-type gathers Urethane material and preparation method thereof.
Background technology
Since Bayer AG's invention, from medical catheter to artificial heart, polyurethane (PU) has in medical instruments field It is widely used.Polyurethane has unique performance, such as relatively excellent biocompatibility, chemical characteristic, remarkable power Performance and processing characteristics etc. are learned, becomes the ideal chose of numerous medical product raw materials, particularly when simultaneously selected materials will be solved When certainly complicated mechanical property and biocompatibility issues, for example prepare interposing catheter, intervention device coating, hemodialysis membrane, The contacting blood device such as artificial heart and making assisted circulation of ventriculus cordis system, medical polyurethane is typically the optimum selection of raw material.At present, Thrombosis, calcification and bacterium infection are including the major complications faced for contacting blood material including medical polyurethane.When Medical material is entered in human body, and tissue and main and material the surface of blood contact, therefore understands that the table with control material Surface properties are the keys for eliminating complication.
Phosphoryl choline polymer has-CH2NO5The compound of P+ groups, comprising polytype, common are two Laurels Acyl group lecithin (DLPC) (as shown in Equation 1), dimyristoyl phosphatidyl choline (DMPC) (as shown in Equation 2), two Palmic acid phosphorus Phosphatidylcholine (DPPC) (as shown in Equation 3), distearoyl phosphatidylcholine (DSPC) (as shown in Equation 4), poly- 2- methacryls Epoxide ethylphosphocholine (PMPC) (as shown in Equation 5) etc..Its interaction very little with various biotic components in blood, i.e. phosphorus Phatidylcholine group is able to maintain that the normal conformation of biotic component in blood makes the outer surface of hemocyte cell membrane have good blood Liquid phase capacitive, therefore critical role is accounted in outer cell membrane, he directly affects how biological cell has an effect with the external world. Based on imitative membrane structure set out design synthesis phosphoryl choline polymer enjoy pass because it has good biocompatibility Note.By the construction for imitating extracellular Lipid bilayer membranes, the material rich in Phosphorylcholine group is disguised it as in vivo The natural component of surrounding so as to which, with excellent biocompatibility, surface is difficult the biofoulings such as adsorbed proteins, platelet, Thrombosiss are prevented, so as to many problems that surface smut causes can be eliminated.The birds of the same feather flock together exploitation of compound of Phosphorylcholine is sought for people Biocompatible materialses are looked for open new approach.
Phosphorylcholine can be widely used in the modified field to polyurethane material.The Phosphorylcholine modification polyurethane of early stage Method be by after 2- methylacryoyloxyethyl Phosphorylcholines (MPC) and methacrylic acid -2- Octyl Nitrite copolymerization by copolymerization Thing is blended with block polyurethane, and develops semi-intercrossing network technology on this basis.Developed with azo two again later Isobutyl is fine for initiator, and MPC is prepared for butyl methacrylate, the copolymerization of first Isooctyl acrylate monomer using radical polymerization Thing.Although the Phosphorylcholine group of the polymer for preparing is located at side chain, the table for being gathered in material is can be very good under water environment Face, plays a part of to increase biocompatibility, but the phosphoryl choline polymer degradation property of free-radical polymerized preparation is very poor, and And blending method causes the mechanical performance of material to reduce, application is very restricted.
Another kind of Phosphorylcholine method of modifying is the surface that Phosphorylcholine group is grafted to polyurethane material, with 2- methyl Acrylyl oxy-ethyl Phosphorylcholine (MPC) and choline glycerophosphatide (GPC) derivant provide compound for PC groups, and with surface Coupling MPC methods, surface coupling aldehyde radical Phosphorylcholine method and surface grafting GPC derivative methods, by PC groups covalence graft to poly- carbon Acid esters type polyurethane surface.The Phosphorylcholine modified biological material that the method is obtained has higher biocompatibility.Although material Material surface grafting Phosphorylcholine group can effectively improve the biocompatibility of material, but this method has technique very multiple It is miscellaneous, it is relatively costly, and it is only applicable to the material of surface comparison rule so as to the problems such as commercialization becomes extremely difficult.
There is a kind of Phosphorylcholine method of modifying to be both-end hydroxy compounds of the synthesis containing Phosphorylcholine group at present, so Carry out chain extension using diisocyanate afterwards and prepare the polyurethane that main chain contains Phosphorylcholine group.This preparation method resulting materials With good biocompatibility, but the Phosphorylcholine group contained in the material is fully located on main chain, in the use of material During substantial portion of choline group be embedded in material internal, it is difficult to be enriched in the surface of material, therefore the material has life Thing limited compatibility, the both-end hydroxy compounds of synthesis Phosphorylcholine group cause the material using the aldehydes matter containing phenyl ring Material is the shortcomings of poisonous mass degradation is had out during long-term use.
The content of the invention
According to above the deficiencies in the prior art, it is an object of the present invention to provide a kind of side chain contains Phosphorylcholine group Polyester type polyurethane material, the polyurethane material Phosphorylcholine group is located on side chain, can effectively platelet and albumen The deposition of matter and the generation of thrombosis is avoided, with higher biocompatibility, while the soft section of polyurethane material is crystallization Polyester, hard section has ordered structure and contains carbamate groups so that material has higher mechanical strength, and main chain Completely the characteristic of hydrophobic is met as degradation speed slower needed for organizational project renovating bracket material, and soft section catabolite is little Carboxylic acids, hard section catabolite are fatty amine and aminoacid, and after materials serve effect non-toxic products quilt can be gradually degraded to Organism absorbs, it is to avoid the injury of second operation, can with prolonged application in organism.
Another object of the present invention is to provide the preparation that a kind of side chain contains the polyester type polyurethane material of Phosphorylcholine group Method, the preparation process is simple, the diisocyanate of selection is the aliphatic diisocyanate containing multiple amido formates, drop Solution product can be absorbed by organism, can for a long time be applied to organism as biomaterial etc..By prepared by this preparation method gathering Ester type polyurethane material for it is complete synthesis, without potential animal derived, while with excellent biocompatibility and mechanical performance, and With biological degradability, catabolite is nontoxic, can be absorbed by organism.
To achieve these goals, the present invention is adopted the following technical scheme that:
The invention provides a kind of side chain contains the polyester type polyurethane material of Phosphorylcholine group, molecular weight is more than 1.8 ×105, membrane material fracture strength more than 42Mpa, elongation at break more than 600%, the adsorbance of protein be less than 2.5 μ g/cm2、 Degradation time is in 105-120d.
Present invention also offers a kind of preparation method of side chain group containing Phosphorylcholine polyester type polyurethane material, including with Lower step:
(1) polyester-diol reacts with excess diisocyanate, obtains both-end isocyanate group prepolymer;
(2) chain extension is carried out to both-end isocyanate group prepolymer with the Phosphorylcholine compound of double amino, obtains side chain phosphorous The polyurethane material of phatidylcholine group.
Preferably, the polyester-diol in step (1) be PGA, PLLA, PDLLA or poly- ε-oneself Lactone, molecular weight is 400~5000, and preferred molecular weight is 500~3000.
Preferably, the diisocyanate in step (1) be 1,6- hexamethylene diisocyanates-BDO -1,6- Hexamethylene diisocyanate (HDI-BDO-HDI), Isosorbide-5-Nitrae-tetramethylene diisocyanate-BDO-methylene of Isosorbide-5-Nitrae-four Group diisocyanate (BDI-BDO-BDI).
Preferably, the concrete preparation method of HDI-BDO-HDI/BDI-BDO-HDI is different with BDO (BDO) and two Cyanate is raw material, and molar ratio is:n-OH:N-NCO=1:4-30, reaction temperature 70-100 DEG C, response time 1-5h is closed Into HDI-BDO-HDI.
Preferably, BDO and 1,6- hexamethylene diisocyanate (HDI) mol ratio are 1:12, under a dry nitrogen atmosphere Reaction system in 4 hours response time, is cooled to room temperature by reaction, 80 DEG C of reaction temperature, obtains white solid, normal hexane washing three Secondary removing excess HDI, normal-temperature vacuum it is dry HDI-BDO-HDI.
Preferably, BDO and Isosorbide-5-Nitrae-tetramethylene diisocyanate (BDI) mol ratio are 1:14, it is anti-under dry nitrogen atmosphere Should, 80 DEG C of reaction temperature, response time 3h cools to room temperature and forms white solid, and normal hexane washs three times and removes excess BDI, normal-temperature vacuum it is dry BDI-BDO-BDI.
Preferably, the addition of the excess diisocyanate described in step (1) is-NCO and-OH mol ratios are 2.0, plus Enter mode and be dissolved in dimethyl sulfoxide (10g/30mL) for diisocyanate, mix with polyester-diol at normal temperatures
Preferably, reaction temperature is 80~100 DEG C in step (1), and the response time is 2.5~6.0h.
Preferably, the Phosphorylcholine compound of the double amino described in step (2) is Lys-PC (such as the institute of formula 6 for concrete structure Show) or Lys-EG-PC (as shown in Equation 7).
Preferably, the addition of double amino Phosphorylcholine compounds is in step (2):-NH2:- NCO=1:2 (mole Than), reaction temperature is 10~20 DEG C, and the response time is 1.0~2.0h.
Preferably, preparation method includes the purification step to the phosphorous phatidylcholine group polyurethane material of side chain:With dichloromethane Alkane or dioxane dissolve, the sedimentation of ice ether, sucking filtration, and normal-temperature vacuum drying is to constant weight.
Preferably, polyurethane material of the side chain obtained in step (2) containing Phosphorylcholine group is dissolved in benign organic molten In agent, the solution that concentration is 4~7% (g/mL) is made into, Jing solvents volatilization film forming prepares polyurethane film material.
Preferably, good solvent is one kind or wherein several of chloroform, dichloromethane, chloroform, acetone or dioxane The mixed solvent planted.Solvent volatilization temperature is 15~25 DEG C, normal pressure 60~90h of volatilization, is dried by normal-temperature vacuum, obtains membrane material Material.
Preferably, the thickness of gained polyurethane film material membrane is 0.18~0.22mm.
Preferably, the polyurethane material can make the various dosage forms required for organism, particularly film, sponge, cartilage Dosage form.
Preferably, the polyurethane material as organizational project renovating bracket material medical domain application.
Beneficial effects of the present invention
1. the soft section of material prepared by the present invention is the polyester of crystallization, and hard section has ordered structure and contains carbamate Base and urine base, can form substantial amounts of hydrogen bond so that material has higher mechanical strength between hard section and between hard section and soft section, And the complete hydrophobic of main chain, meets as degradation speed slower needed for organizational project renovating bracket material.The polyurethane material Soft section catabolite be small carboxylic acid molecules, hard section catabolite be fatty amine and aminoacid, can be by after materials serve effect Gradually it is degraded to non-toxic products to be absorbed by organism, it is to avoid the injury of second operation, can with prolonged application in organism.
2. the material Phosphorylcholine group that prepared by the present invention is located at the side chain of polymer, with higher hydrophilic, is giving birth to The surface of material can be gathered in object under water environment, not only will not be adsorbed and precipitating proteins, will not also cause platelet to swash Work cause the untoward reaction such as blood coagulation, it is to avoid thrombosis generation, with high biocompatibility.
3. preparation process is simple of the present invention, conventional method can meet to prepare and require, and can be prepared into various dosage forms, have Higher commercialization prospect.
Description of the drawings
The shape need of Fig. 1, national regulations measuring mechanical property PU films.
The platelet viscosity SEM photograph of Fig. 2, sample A6.
Specific embodiment
With reference to specific embodiment, the invention will be further described.
Embodiment 1
By 0.01mol PLLA (PLLA, Mn=2000) (it is dissolved in dimethyl sulfoxide with 0.02mol HDI-BDO-HDI In:10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 80 DEG C, after reaction 4.0h, is cooled to 18 DEG C, 0.01mol Lys-PC, stirring is added when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After mixing 1h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain and contain to constant weight The polyurethane material A1 of Phosphorylcholine group.
The preparation of membrane material:A1 is dissolved in organic solvent dioxane, concentration is made into for the molten of 6.5% (g/mL) Liquid, using Teflon mould in 25 DEG C of normal pressures volatilization 80h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material Material, the thickness of the membrane material of gained is 0.20mm.
Embodiment 2
By 0.01mol poly-epsilon-caprolactone (PCL, Mn=2000) (it is dissolved in dimethyl sulfoxide with 0.02mol HDI-BDO-HDI In:10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 85 DEG C, after reaction 3.5h, is cooled to 18 DEG C, 0.01mol Lys-PC, stirring is added when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After mixing 1h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain and contain to constant weight The polyurethane material A2 of Phosphorylcholine group.
The preparation of membrane material:A2 is dissolved in organic solvent chloroform, concentration is made into for the molten of 5.5% (g/mL) Liquid, using Teflon mould in 24 DEG C of normal pressures volatilization 90h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material Material, the thickness of the membrane material of gained is 0.19mm.
Embodiment 3
By 0.01mol poly-epsilon-caprolactone (PCL, Mn=1500) (it is dissolved in dimethyl sulfoxide with 0.02mol HDI-BDO-HDI In:10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 85 DEG C, after reaction 3.5h, is cooled to 18 DEG C, 0.01mol Lys-PC, stirring is added when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After mixing 1.5h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain to constant weight Polyurethane material A3 containing Phosphorylcholine group.
The preparation of membrane material:A3 is dissolved in organic solvent chloroform, the solution that concentration is 4% (g/mL) is made into, Using Teflon mould in 15 DEG C of normal pressures volatilization 60h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material, The thickness of the membrane material of gained is 0.18mm.
Embodiment 4
By 0.01mol poly-epsilon-caprolactone (PCL, Mn=1000) (it is dissolved in dimethyl sulfoxide with 0.02mol BDI-BDO-BDI In:10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 85 DEG C, after reaction 3.5h, is cooled to 18 DEG C, 0.01mol Lys-PC, stirring is added when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After mixing 1.5h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain to constant weight Polyurethane material A4 containing Phosphorylcholine group.
The preparation of membrane material:A4 is dissolved in organic solvent dichloromethane, the solution that concentration is 5% (g/mL) is made into, Using Teflon mould in 20 DEG C of normal pressures volatilization 65h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material, The thickness of the membrane material of gained is 0.20mm.
Embodiment 5
By 0.01mol poly (l-lactic acid) (PLLA, Mn=1000) (be dissolved in dimethyl sulfoxide with 0.02mol BDI-BDO-BDI: 10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 80 DEG C, after reaction 4.0h, is cooled to 20 DEG C, add 0.01mol Lys-PC, stirring when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After 1.5h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain and contain to constant weight Phosphorylcholine group can polyurethane material A5.
The preparation of membrane material:A5 is dissolved in organic solvent dichloromethane, the solution that concentration is 5% (g/mL) is made into, Using Teflon mould in 20 DEG C of normal pressures volatilization 60h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material, The thickness of the membrane material of gained is 0.21mm.
Embodiment 6
By 0.01mol poly-L-lactic acid (PLLA, Mn=1000) (be dissolved in dimethyl sulfoxide with 0.02mol BDI-BDO-BDI: 10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 80 DEG C, after reaction 4.0h, is cooled to 18 DEG C, add 0.01mol Lys-EG-PC, stirring when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, After stirring 1.5h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side to constant weight Polyurethane material A6 of the chain containing Phosphorylcholine group.
The preparation of membrane material:A6 is dissolved in organic solvent dioxane, concentration is made into for the molten of 5.5% (g/mL) Liquid, using Teflon mould in 22 DEG C of normal pressures volatilization 80h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material Material, the thickness of the membrane material of gained is 0.22mm.
Embodiment 7
By the poly- D of 0.01mol, Pfansteihl (PDLLA, Mn=1000) (it is dissolved in dimethyl sulfoxide with 0.02mol BDI-BDO-BDI In:10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 90 DEG C, after reaction 4.0h, is cooled to 18 DEG C, 0.01mol Lys-EG-PC, stirring is added when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount Alkane, after stirring 1.5h, adds dichloromethane to concentration about 15wt%, the sedimentation of ice ether, sucking filtration, normal-temperature vacuum drying to constant weight, Obtain polyurethane material A7 of the side chain containing Phosphorylcholine group.
The preparation of membrane material:A7 is dissolved in organic solvent-acetone, the solution that concentration is 5.5% (g/mL) is made into, is made With Teflon mould in 25 DEG C of normal pressures volatilization 75h, after film is removed from mould Jing normal-temperature vacuums it is dry membrane material, institute The thickness of the membrane material for obtaining is 0.20mm.
Embodiment 8
By 0.01mol polylactide (PGA, Mn=1000) (be dissolved in dimethyl sulfoxide with 0.02mol HDI-BDO-HDI: 10g/30mL) it is placed in there-necked flask, drying nitrogen protection, mechanical agitation, is warming up to 80 DEG C, after reaction 4.0h, is cooled to 18 DEG C, add 0.01mol Lys-PC, stirring when system viscosity becomes cannot normally be stirred greatly, dichloromethane to be added in right amount, stirred After 2h, add dichloromethane to concentration about 15wt%, ice ether sedimentation, sucking filtration, normal-temperature vacuum drying obtains side chain phosphorous to constant weight The polyurethane material A8 of phatidylcholine group.
The preparation of membrane material:A8 is dissolved in organic solvents, chloroform, the solution that concentration is 6% (g/mL) is made into, is used Teflon mould in 23 DEG C of normal pressures volatilization 80h, by normal-temperature vacuum it is dry membrane material, film is removed from mould gained Membrane material thickness be 0.22mm.
Analysis method
Analysis below method is used for all of embodiment, unless otherwise indicated.
Molecular weight and molecular weight distribution:Poly- ammonia is determined using Alpha type gel permeation chrommatographs (GPC) of Water companies of the U.S. The molecular weight and molecualr weight distribution of ester, 4mg samples are dissolved in 2mL tetrahydrofurans, and with 0.4 μm of filtering head special chromatogram bottle is filled into In, mobile phase speed is 0.5mL/min, and chromatograph box temperature is set to 35 DEG C, and standard specimen is monodisperse polystyrene.
Degradation property:In the membrane material immersion normal saline circular by a diameter of 10mm is cut into, 37 DEG C of constant temperature are maintained, with one It is the state that the cycle observes membrane material, when membrane material produces fragment, loses mechanical performance, it is believed that degraded is completed, it is determined as degraded Time.
Mechanical performance:The tensile property of the polyurethane film synthesized for test, using Dongguan, Guangdong Heng Yu Instrument Ltd. The computermatic single-column tensile testing machine of HY939C types determine the tensile strength and elongation at break of film.Before on-test, first by sample Product soak 3min in normal saline, then make dumbbell shape model, and the method specified according to GB GB/T1040.2-2006 is entered Row is determined, as shown in Figure 1.
Water contact angle measurement:Water contact angle test is carried out in thin film with air contact one side, distilled water (droplet size:2μ L), temperature:25 DEG C, contact angle numerical value of the water drop contact surface in about 1min is determined, take 5 points and make meansigma methodss.
Protein adsorbance:The polymeric film of 1cm × 1cm is soaked in the phosphate buffer of pH=7.4 (PBS) and is filled Divide swelling equilibrium, during the bovine serum albumen solution (BSA) that concentration is 0.6g/L is placed on after taking-up, in 37 DEG C of water bath with thermostatic control Middle immersion 2h.Polymeric film is taken out after end, with the abundant drip washing of PBS buffer solution 3 times.Then with the SDS solution of 1% (w/w) (PBS solution) is cleaned by ultrasonic 20min, accurately pipettes same volume cleanout fluid in tool plug test tube, adds Micro-BcATMEgg (PierceInc., Rockford, 23235), are sufficiently mixed white matter detection kit working solution, sealing, 60 DEG C of constant temperature water bath 1h. Finally naturally cool to room temperature, using ultraviolet-visible spectrophotometer at 562nm wavelength mensuration absorbance, according to standard Curve calculates adsorbance, takes the meansigma methodss of 3 samples.
Platelet adhesion reaction is tested:Fresh blood is extracted from healthy rabbit hearts, the citric acid that mass fraction is 3.8% is added Sodium solution is 9 as the ratio of anticoagulant, whole blood and anticoagulant:1, the whole blood for adding anticoagulant is put in centrifuge, just It is 1400r/min that secondary centrifugation arranges rotating speed, and 10min is centrifuged;Then supernatant recentrifuge is drawn, arranging rotating speed is still 1400r/min, is centrifuged 15min, and the supernatant is platelet poor plasma (PRP), draws about 3/4 supernatant and discards, and residue is For PRP;By modified polyurethane film (1.0 × 1.0cm2) 24 orifice plates are positioned over, first it is immersed in the PBS bufferings of PH=7.4 4h in solution, then under 37 DEG C of constant temperature, in PRP solution 1h is incubated.Take the film out, with PBS buffer solution 3 times are rinsed repeatedly To remove unadsorbed platelet, then film is immersed in again the blood of 30min fixation surfaces in 2.5% glutaraldehyde PBS solution Platelet.And then by film be sequentially placed in the ethanol water of variable concentrations gradient (50,60,70,80,90,100%) carry out by Level dehydration, soaks 30min in the solution of every kind of concentration, is finally dried at room temperature, metal spraying, using S-4800 types SEM (Japan Hitachi, Ltd) observation film surface platelet adhesion reaction situation.
The performance of polyurethane film material of the side chain containing Phosphorylcholine group is as shown in table 1 in embodiment 1-8.
The platelet adhesion stereoscan photograph of polyurethane film material (A6) of the side chain containing Phosphorylcholine group in embodiment 6 As shown in Figure 1.
The biological assessment test of polyurethane film material of the side chain containing Phosphorylcholine group is as shown in table 2 in embodiment 1-8.
The side chain of table 1 contains mechanical performance, surface hydrophilicity and the protein adsorbance of the polyurethane film of Phosphorylcholine group
As shown in Table 1, the poly- ammonia material of side chain prepared by this patent is provided method containing Phosphorylcholine group have compared with High molecular weight, its corresponding membrane material has very high fracture strength, meets bio-tissue engineering renovating bracket material Demand.With the increase of hard section (segment of amido-containing acid ester base and urine base) content, fracture strength increases.The degraded of membrane material Time is all higher than 15 weeks, up to 17 weeks, examine prepared by film it is relatively thin, specific surface area is larger, if prepared by dosage form Shape into required for organizational project renovating bracket material, its degradation time can be greatly increased.The degradation time Phosphorylcholine of film Content and urethane raw species it is relevant, modified polyurethane material degree of crystallinity is higher, degrade it is slower.Its water contact angle and egg The rule of white matter adsorbance is consistent, i.e., contact angle is less, and surface hydrophilicity is higher, and protein adsorbance is less.With phosphinylidyne The increase of choline group content, the Phosphorylcholine group of side chain forms hydrophilic interface due to the mutual aggressiveness of hydrophilic in water, Simultaneously because the high biocompatibility of Phosphorylcholine group, its adsorbance to protein is also reduced, greatly improved medical The biocompatibility of polyurethane material.The adsorbance of the protein of the sample in this patent embodiment is less than 2.2 μ g/cm2, or even Less than 1.5 μ g/cm2, show that the material shows splendid biocompatibility, organism can be long-term used in.
It will be noted from fig. 1 that the platelet counts of Phosphorylcholine modified polyurethane film surface adhesion are seldom, and big portion Point platelet is not assembled, and remains in that original pattern.Show that the material has excellent low platelet Adhesion property.
Test biology of polyurethane film material (sample A1-A8) of the side chain of table 2. containing Phosphorylcholine group
Antibacterial is tested It is aseptic GB/T14233.2-2005 chapter 2
Cytotoxicity <I levels GB/T14233.2-2005
Intradermal zest Stimulate without Intradermal GB/T14233.10-2005
Sensitization Without sensitization GB/T14233.10-2005
Acute systemic toxicity No significant difference GB/T14233.11-2011
As shown in Table 2, the biology performance testing result of the membrane material prepared by embodiment of the present invention 1-8 shows each reality Applying example can obtain nontoxic, non-stimulated, good biocompatibility and meet the material of Clinical practice requirement.
Although giving detailed description to the specific embodiment of the present invention above and illustrating, it should be noted that We can carry out various equivalent changes and modification to above-mentioned embodiment according to the conception of the present invention, and the function produced by it is made With still without departing from description and accompanying drawing covered it is spiritual when, all should be within protection scope of the present invention.

Claims (10)

1. a kind of side chain contains Phosphorylcholine group polyester type polyurethane material, it is characterised in that:Described PAUR Material soft section is the polyester of crystallization, and hard section contains carbamate groups, and polyurethane material molecular weight is more than 1.8 × 105, membrane material Material fracture strength is less than 2.2 μ g/cm more than 42Mpa, elongation at break more than the adsorbance of 600%, protein2, degradation time In 105-120d.
2. a kind of preparation method of side chain group containing Phosphorylcholine polyester type polyurethane material, it is characterised in that:
Comprise the following steps:
(1) polyester-diol reacts with excess diisocyanate, obtains both-end isocyanate-based prepolymers,
(2) chain extension is carried out to both-end isocyanate-based prepolymers with the Phosphorylcholine compound of double amino, obtains side chain containing phosphinylidyne The polyurethane material of choline group.
3. preparation method according to claim 2, it is characterised in that:Polyester-diol described in step (1) is the friendship of poly- second Ester, PLLA, PDLLA or poly-epsilon-caprolactone, described polyester-diol molecular weight is 400~5000, preferably Molecular weight is 500~3000.
4. preparation method according to claim 2, it is characterised in that:Described diisocyanate in step (1) is 1, 6- hexamethylene diisocyanates-BDO -1,6- hexamethylene diisocyanates, the Carbimide. of Isosorbide-5-Nitrae-tetramethylene two Ester -1,4- butanediol -1,4- tetramethylene diisocyanates.
5. preparation method according to claim 2, it is characterised in that:Excess diisocyanate described in step (1) Addition is-NCO and-OH mol ratios are 2.0, and reaction temperature is 80~100 DEG C, and the response time is 2.5~6.0h.
6. preparation method according to claim 2, it is characterised in that:The Phosphorylcholine of the double amino described in step (2) Compound is that concrete structure is Lys-PC (as shown in Equation 6) or Lys-EG-PC (as shown in Equation 7), Phosphorylcholine compound addition For:-NH2It is 1 with-NCO mol ratios:2, reaction temperature is 10~20 DEG C, and the response time is 1.0~2.0h,
7. preparation method according to claim 2, it is characterised in that:Described preparation method is included to the step (2) The purification step of side chain group containing Phosphorylcholine polyurethane material:Dissolved with dichloromethane or dioxane, the sedimentation of ice ether is taken out Filter, normal-temperature vacuum drying is to constant weight.
8. preparation method according to claim 2, it is characterised in that:The side chain obtained in step (2) is contained into Phosphorylcholine The polyurethane material of group is dissolved in organic solvent, is made into the solution that concentration is 4~7% (g/mL), Jing solvents volatilization film forming Polyurethane film material is prepared, described good solvent is chloroform, dichloromethane, chloroform, acetone or dioxane A kind of or wherein several mixed solvent, solvent volatilization temperature is 15~25 DEG C, normal pressure 60~90h of volatilization, by normal-temperature vacuum It is dried, obtains polyurethane film material, the thickness of the membrane material of gained is 0.18~0.22mm.
9. according to the arbitrary described preparation method of claim 2-8, it is characterised in that:Preparing gained polyurethane material can make Various dosage forms required for organism, particularly film, sponge, cartilage dosage form.
10. polyester type polyurethane material of the side chain according to claim 1 containing Phosphorylcholine group makees organizational project reparation Application of the timbering material in medical domain.
CN201611235863.2A 2016-12-28 2016-12-28 A kind of polyester type polyurethane material of side chain group containing Phosphorylcholine and preparation method thereof Active CN106674486B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611235863.2A CN106674486B (en) 2016-12-28 2016-12-28 A kind of polyester type polyurethane material of side chain group containing Phosphorylcholine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611235863.2A CN106674486B (en) 2016-12-28 2016-12-28 A kind of polyester type polyurethane material of side chain group containing Phosphorylcholine and preparation method thereof

Publications (2)

Publication Number Publication Date
CN106674486A true CN106674486A (en) 2017-05-17
CN106674486B CN106674486B (en) 2019-09-24

Family

ID=58871842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611235863.2A Active CN106674486B (en) 2016-12-28 2016-12-28 A kind of polyester type polyurethane material of side chain group containing Phosphorylcholine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106674486B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107216435A (en) * 2017-06-26 2017-09-29 山东师范大学 A kind of new side chain is the poly- of phosphatide polyethylene glycol(Urethane urea)And preparation method thereof
CN109054485A (en) * 2018-06-27 2018-12-21 佛山市博新生物科技有限公司 A kind of antibacterial coating liquid and its preparation method and application
CN111234170A (en) * 2020-01-15 2020-06-05 中国科学院长春应用化学研究所 Polyurethane material, preparation method thereof and application of polyurethane material in artificial meniscus material
WO2021254348A1 (en) * 2020-06-16 2021-12-23 杭州启明医疗器械股份有限公司 Super-lubricative coating for interventional valve delivery system and preparation method therefor
CN113956437A (en) * 2021-10-28 2022-01-21 赛克赛斯生物科技股份有限公司 Polyurethane sponge and preparation method and application thereof
CN114213615A (en) * 2021-12-29 2022-03-22 广东粤港澳大湾区黄埔材料研究院 Swelling-resistant phosphorylcholine modified polyurethane material and preparation method thereof
CN115417963A (en) * 2022-09-19 2022-12-02 苏州百孝医疗科技有限公司 Biocompatible polycarbonate polyurethane, preparation method and application

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1390842A (en) * 2002-05-30 2003-01-15 南京南大表面和界面化学工程技术研究中心有限责任公司 Phosphonic choline containing hydroxy, its preparing process and process for preparing biological material containing it
CN1569917A (en) * 2004-05-11 2005-01-26 四川大学 Polyurethane material with side chain possessing fluorophosphatidylcholine and its preparation method
US20060041160A1 (en) * 2003-02-18 2006-02-23 Tokai University Compound having phosphorylcholine group, polymer thereof and process for producing the same
US20100036081A1 (en) * 2006-09-01 2010-02-11 Tokai University Educational System Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer
CN101787047A (en) * 2010-01-22 2010-07-28 四川大学 Fluorocarbon chain or/and hydrocarbon chain containing phosphatidylcholine blocking agent with hydroxyl or amino at tail end and polyurethane material for blocking same
CN104031287A (en) * 2014-06-19 2014-09-10 山东赛克赛斯药业科技有限公司 Preparation method of biodegradable nasal hemostatic sponge
JP2015061901A (en) * 2013-08-21 2015-04-02 学校法人東海大学 Nanosheet dispersion liquid comprising polymer having phosphorylcholine group

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1390842A (en) * 2002-05-30 2003-01-15 南京南大表面和界面化学工程技术研究中心有限责任公司 Phosphonic choline containing hydroxy, its preparing process and process for preparing biological material containing it
US20060041160A1 (en) * 2003-02-18 2006-02-23 Tokai University Compound having phosphorylcholine group, polymer thereof and process for producing the same
CN1569917A (en) * 2004-05-11 2005-01-26 四川大学 Polyurethane material with side chain possessing fluorophosphatidylcholine and its preparation method
US20100036081A1 (en) * 2006-09-01 2010-02-11 Tokai University Educational System Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer
CN101787047A (en) * 2010-01-22 2010-07-28 四川大学 Fluorocarbon chain or/and hydrocarbon chain containing phosphatidylcholine blocking agent with hydroxyl or amino at tail end and polyurethane material for blocking same
JP2015061901A (en) * 2013-08-21 2015-04-02 学校法人東海大学 Nanosheet dispersion liquid comprising polymer having phosphorylcholine group
CN104031287A (en) * 2014-06-19 2014-09-10 山东赛克赛斯药业科技有限公司 Preparation method of biodegradable nasal hemostatic sponge

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
梁飞,等: ""可降解聚碳酸酯基聚氨酯的仿生改性及其性能研究"", 《现代化工》 *
梁飞,等: ""生物相容性优异的聚碳酸酯基聚氨酯仿生改性研究"", 《应用化工》 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107216435A (en) * 2017-06-26 2017-09-29 山东师范大学 A kind of new side chain is the poly- of phosphatide polyethylene glycol(Urethane urea)And preparation method thereof
CN107216435B (en) * 2017-06-26 2020-01-31 山东师范大学 poly (urethane-urea) with side chain of phosphatide polyethylene glycol and preparation method thereof
CN109054485A (en) * 2018-06-27 2018-12-21 佛山市博新生物科技有限公司 A kind of antibacterial coating liquid and its preparation method and application
CN111234170A (en) * 2020-01-15 2020-06-05 中国科学院长春应用化学研究所 Polyurethane material, preparation method thereof and application of polyurethane material in artificial meniscus material
WO2021254348A1 (en) * 2020-06-16 2021-12-23 杭州启明医疗器械股份有限公司 Super-lubricative coating for interventional valve delivery system and preparation method therefor
CN113956437A (en) * 2021-10-28 2022-01-21 赛克赛斯生物科技股份有限公司 Polyurethane sponge and preparation method and application thereof
CN114213615A (en) * 2021-12-29 2022-03-22 广东粤港澳大湾区黄埔材料研究院 Swelling-resistant phosphorylcholine modified polyurethane material and preparation method thereof
CN114213615B (en) * 2021-12-29 2022-09-16 广东粤港澳大湾区黄埔材料研究院 Swelling-resistant phosphorylcholine modified polyurethane material and preparation method thereof
CN115417963A (en) * 2022-09-19 2022-12-02 苏州百孝医疗科技有限公司 Biocompatible polycarbonate polyurethane, preparation method and application
WO2024060897A1 (en) * 2022-09-19 2024-03-28 苏州百孝医疗科技有限公司 Biocompatible polycarbonate polyurethane, preparation method therefor, and use thereof

Also Published As

Publication number Publication date
CN106674486B (en) 2019-09-24

Similar Documents

Publication Publication Date Title
CN106674486A (en) Polyester type polyurethane material with side chain containing phosphorylcholine group and preparation method thereof
CN106674484B (en) A kind of side chain group containing Phosphorylcholine polyether polyurethane material and preparation method thereof
Lamba Polyurethanes in biomedical applications
US4996054A (en) Antithrombogenic, non-calcifying material and method of making articles for medical purposes
CN108478870B (en) Dura mater biological patch and preparation method thereof
AU771243B2 (en) Biocompatible medical articles and process for their production
CN106589290B (en) A kind of high-biocompatibility Phosphorylcholine modified polyurethane material and preparation method thereof
Boretos et al. Segmented polyurethane: a polyether polymer, II. Two years experience
CN107789677B (en) Preparation method and application of hyperbranched polyimide anticoagulant antibacterial material
CN104312140B (en) Polyurethane (PU)/small intestine submucosa (SIS) membrane composite material and application thereof
WO1987002684A1 (en) Lipid containing plastics
CN106967206B (en) Hydrophilic lubrication medical polyurethane material and its preparation method and application
CN107216435A (en) A kind of new side chain is the poly- of phosphatide polyethylene glycol(Urethane urea)And preparation method thereof
CN104341608B (en) The preparation method of polyurethane/submucous layer of small intestine composite
Nakabayashi et al. Copolymers of 2‐methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials
JP2002504601A (en) Sulfated hyaluronic acid covalently bonded to polyurethane and sulfated derivatives thereof, and methods for their preparation
Rajeshkumar et al. Tissue mimicking material an idealized tissue model for clinical applications: a review
US4927410A (en) Method for fabricating prosthesis material
Nyilas et al. Surface microstructural factors and the blood compatibility of a silicone rubber
JPH06502087A (en) Non-thrombogenic surfaces
CN109847099B (en) Multilayer soft tissue repair material and preparation method thereof
CN108912305B (en) Cholesterol side chain liquid crystal polyurethane urea material and preparation method thereof
Resiak et al. Modified polyurethanes for biomedical applications
JP3509829B2 (en) Anticoagulant material
CN107899069A (en) A kind of preparation method of medical collagen complex stephanoporate bracket

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20201112

Address after: 226000 266 Century Avenue, Nantong hi tech Zone, Nantong, Jiangsu

Patentee after: Nantong Yaoxiang Technology Co., Ltd

Address before: 250014 No. 88 East Wenhua Road, Shandong, Ji'nan

Patentee before: SHANDONG NORMAL University

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220401

Address after: 226000 203c, building A45, sihaijiayuan, No. 1, Huanghai Second Road, Yangkou Town, Rudong County, Nantong City, Jiangsu Province

Patentee after: Nantong jieshida New Material Co.,Ltd.

Address before: 226000 266 Century Avenue, Nantong hi tech Zone, Nantong City, Jiangsu Province

Patentee before: Nantong Yaoxiang Technology Co.,Ltd.

TR01 Transfer of patent right